Drug Markets/Dabigatran Etexilate

Dabigatran Etexilate

34 NDCs across 9 manufacturers|34 Generic,0 Brand

Dabigatran Etexilate is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Dabigatran Etexilate is available as 34 NDCs from 9 manufacturers (34 generic, 0 brand), with NADAC prices from $0.82 to $0.95 per EAa 15% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

34

34G / 0B

Manufacturers

9

competing in market

Price Spread

$0.82 – $0.95

per EA

7d Activity

340 flat

avg -4.3% WoW · of 34 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

34 NDCs total, 34 shown

Drug Price 7d Change
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 110 MG CP
$0.9460
per EA
-2.84%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 75 MG CAP
$0.8430
per EA
-6.19%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%
DABIGATRAN ETEXILATE 150 MG CP
$0.8226
per EA
-3.54%

Frequently Asked Questions

What is Dabigatran Etexilate used to treat?

Dabigatran Etexilate is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.

How many Dabigatran Etexilate products are on the market?

The Dabigatran Etexilate drug market contains 34 NDCs from 9 manufacturers — 34 generic and 0 brand products.

What is the price range for Dabigatran Etexilate?

NADAC reference prices for Dabigatran Etexilate range from $0.8226 to $0.9460 per EA — a 15% difference between cheapest and most expensive.

Which manufacturers make Dabigatran Etexilate?

9 manufacturers list Dabigatran Etexilate in NADAC. Ranked by number of NDCs, the largest are Camber Pharmaceuticals Inc. (6), Alembic Pharmaceuticals Inc. (6), Major Pharmaceuticals (5), Apotex Corp. (3), Dr. Reddy's Laboratories Inc. (3).

How has the price of Dabigatran Etexilate changed recently?

Over the past 7 days, 0 Dabigatran Etexilate NDCs rose and 34 fell, with a market-wide average change of -4.3%.